C. Fuhrman and M. Delmas, ??pid??miologie descriptive de la bronchopneumopathie chronique obstructive (BPCO) en France, Revue des Maladies Respiratoires, vol.27, issue.2, pp.160-168, 2010.
DOI : 10.1016/j.rmr.2009.08.003

. Haute-autorité?deautorité?de and . Santé, Pertinence du recours à l'hospitalisation pour bronchopneumopathie chronique surinfectée GHM 04M20 Saint Denis la Plaine: HAS; 2012. [En ligne] Disponible sur, 2014.

D. Piperno and G. Huchon, The burden of COPD in France: results from the confronting COPD survey, Respiratory Medicine, vol.97, pp.33-42, 2003.
DOI : 10.1016/S0954-6111(03)80023-9

A. Papi and C. Bellettato, Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.10, pp.1114-1135, 2006.
DOI : 10.1164/rccm.200506-859OC

K. Rabe and S. Hurd, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.6, pp.532-55, 2007.
DOI : 10.1164/rccm.200703-456SO

D. Vollenweider and H. Jarrett, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, vol.164, issue.2, p.10257, 2012.
DOI : 10.1002/14651858.CD010257

V. Stichele and R. , Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002), Journal of Antimicrobial Chemotherapy, vol.58, issue.1, pp.159-67, 2006.
DOI : 10.1093/jac/dkl147

S. Bronzwaer and O. Cars, A European Study on the Relationship between Antimicrobial Use and Antimicrobial Resistance, Emerging Infectious Diseases, vol.8, issue.3, pp.278-82, 2002.
DOI : 10.3201/eid0803.010192

L. Simon and F. Gauvin, Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis, Clinical Infectious Diseases, vol.39, issue.2, pp.206-223, 2004.
DOI : 10.1086/421997

R. Stockley, Relationship of Sputum Color to Nature and Outpatient Management of Acute Exacerbations of COPD, Chest, vol.117, issue.6, pp.1638-1683, 2000.
DOI : 10.1378/chest.117.6.1638

P. Van-der-valk and E. Monninkhof, Clinical Predictors of Bacterial Involvement in Exacerbations of Chronic Obstructive Pulmonary Disease, Clinical Infectious Diseases, vol.39, issue.7, pp.980-986, 2004.
DOI : 10.1086/423959

N. Soler and M. Esperatti, Sputum purulence:guided antibiotic use in hospitalised patients with exacerbations of COPD, Eur Respir J Off J Eur Soc Clin Respir Physiol, vol.40, issue.6, pp.1344-53, 2012.

O. Régional-de and L. Santé, Indicateurs liés aux broncho:pneumopathies chroniques obstructives (BPCO) à la Réunion. ORS. [En ligne]. Disponible sur: http://www.ors:reunion.org, p.pdf, 2014.

C. Fuhrman and N. Roche, Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998???2007, Respiratory Medicine, vol.105, issue.4, pp.595-601, 1998.
DOI : 10.1016/j.rmed.2010.11.014

URL : https://hal.archives-ouvertes.fr/hal-00596821

C. Fuhrman and I. National-de-veille-sanitaire, Asthme et BPCO : taux d'hospitalisation et de mortalité dans les départements d'outre:mer et en France métropolitaine, BEH, 2005.

W. Albrich, Effectiveness and safety of procalcitonin:guided antibiotic therapy in lower respiratory tract infections in « real life »: an international, multicenter poststudy survey (ProREAL), Arch Intern Med, vol.172, issue.9, pp.715-737, 2012.

F. Müller, C. Crain, and M. , Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia, Chest, vol.138, issue.1, pp.121-130, 2010.
DOI : 10.1378/chest.09-2920

P. Schuetz, C. Crain, and M. , Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections, JAMA, vol.302, issue.10, pp.1059-66, 2009.
DOI : 10.1001/jama.2009.1297

P. Schuetz and B. Müller, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev Online, vol.9, p.7498, 2012.

D. Stolz, C. Crain, and M. , Antibiotic Treatment of Exacerbations of COPD, Chest, vol.131, issue.1, pp.9-19, 2007.
DOI : 10.1378/chest.06-1500

S. Nseir and B. Cavestri, Factors Predicting Bacterial Involvement in Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease, Respiration, vol.76, issue.3, pp.253-60, 2008.
DOI : 10.1159/000139611

D. Hurst, Audit and feedback had small but potentially important improvements in professional practice, Evidence-Based Dentistry, vol.317, issue.1, pp.8-9, 2013.
DOI : 10.1038/sj.ebd.6400910

P. Davey, Interventions to improve antibiotic prescribing practices for hospital inpatients, Cochrane Database Syst Rev, vol.4, p.3543, 2013.

H. Autorité and D. Santé, Mesures quantitatives pour évaluer les interventions visant à améliorer les pratiques. Saint Denis La Plaine: HAS. 2007. [En ligne] Disponible sur, 2014.

C. Fuhrman and M. Delmas, Hospitalisations pour exacerbations de BPCO : comment les identifier à partir des données du programme de médicalisation des systèmes d'information ? Saint:Maurice (Fra) : Institut de veille sanitaire Disponible sur : http://www.invs.sante.fr 30. Direction régionale des affaires sanitaires et sociales, 2009.

E. Lemarié, Le feu de bois, source d???inflammation respiratoire et syst??mique, Revue des Maladies Respiratoires, vol.23, issue.5, pp.166-173, 2006.
DOI : 10.1016/S0761-8425(06)72027-7

S. Jefferies, A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients, Crit Care Resusc J Australas Acad Crit Care Med, vol.13, issue.3, pp.194-203, 2011.

M. Pavlovi? and N. Radlovi?, Comparison of different methods of temperature measurement in children, Medicinski pregled, vol.61, issue.11-12, pp.615-624, 2008.
DOI : 10.2298/MPNS0812615P

K. Kristoffersen and O. Søgaard, Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission???a randomized trial, Clinical Microbiology and Infection, vol.15, issue.5, pp.481-488, 2009.
DOI : 10.1111/j.1469-0691.2009.02709.x

L. Bouadma and C. Luyt, Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial, The Lancet, vol.375, issue.9713, pp.463-74, 2010.
DOI : 10.1016/S0140-6736(09)61879-1

B. Tang and G. Eslick, Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis, The Lancet Infectious Diseases, vol.7, issue.3, pp.210-217, 2007.
DOI : 10.1016/S1473-3099(07)70052-X

C. Daubin and J. Parienti, Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study, BMC Infectious Diseases, vol.162, issue.8, p.145, 2008.
DOI : 10.1164/ajrccm.162.2.9909095

G. Jebrak, Recommandations et prise en charge de la BPCO en France??: les recommandations sur la prise en charge de la BPCO ne sont pas suivies dans la vraie vie??!, Revue des Maladies Respiratoires, vol.27, issue.1, pp.11-18, 2010.
DOI : 10.1016/j.rmr.2009.08.002

I. Gheffari, ??valuation des pratiques professionnelles pour la prise en charge de la BPCO au CHU de Montpellier, Revue des Maladies Respiratoires, vol.27, issue.5, pp.457-62, 2010.
DOI : 10.1016/j.rmr.2010.03.017

M. Cabana, C. Rand, and N. Powe, Why Don't Physicians Follow Clinical Practice Guidelines?, JAMA, vol.282, issue.15, pp.1458-65, 1999.
DOI : 10.1001/jama.282.15.1458

A. Régionale-de-santé-océan-indien and . Statiss, ARS Océan Indien . 2014 [en ligne] Disponible sur: http://www.ars.ocean: indien.sante.fr/fileadmin, 2013.

O. Burkhardt and S. Ewig, Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection, European Respiratory Journal, vol.36, issue.3, pp.601-608, 2010.
DOI : 10.1183/09031936.00163309

M. Briel and P. Schuetz, Procalcitonin:guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care, Arch Intern Med, vol.168, issue.18, 2008.

R. Aabenhus, J. Jensen, and . Us, Procalcitonin:guided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet?, Prim Care Respir J J Gen Pract Airw Group, vol.20, issue.4, pp.360-367, 2011.

H. Melbye and N. Francis, Inflammatory markers are helpful when treating LRTI in primary care, Primary Care Respiratory Journal, vol.57, issue.4, p.367, 2011.
DOI : 10.1093/fampra/cmp088

V. Vugt and S. , Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study, BMJ, vol.346, issue.apr30 1, p.2450, 2013.
DOI : 10.1136/bmj.f2450

P. Schuetz, C. Crain, M. Müller, and B. , Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections::hope for hype, Swiss Med Wkly. 13 juin, vol.139, issue.23, pp.24318-24344, 2009.